688310 迈得医疗
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)0.751-2.34511.6558.4658.590
总资产报酬率 ROA (%)0.547-1.8149.1256.9917.607
投入资产回报率 ROIC (%)0.603-2.05410.5607.8778.202

边际利润分析
销售毛利率 (%)38.92843.85251.30850.45750.122
营业利润率 (%)0.777-9.96826.64822.66521.483
息税前利润/营业总收入 (%)1.674-11.57624.96119.83020.434
净利润/营业总收入 (%)-1.290-10.92022.82420.08520.275

收益指标分析
经营活动净收益/利润总额(%)-488.856149.26975.24680.33583.368
价值变动净收益/利润总额(%)45.450-7.6652.1383.5570.660
营业外收支净额/利润总额(%)65.5576.279-0.4240.3483.815

偿债能力分析
流动比率 (X)2.7683.7823.7833.2935.953
速动比率 (X)2.1192.9123.0282.6894.975
资产负债率 (%)28.36819.74118.22820.09713.268
带息债务/全部投入资本 (%)21.25113.0738.0906.9723.228
股东权益/带息债务 (%)357.928650.8611,112.1691,309.4232,943.593
股东权益/负债合计 (%)243.949389.527426.448392.593655.147
利息保障倍数 (X)-2.88112.311-15.844-6.805-10.748

营运能力分析
应收账款周转天数 (天)156.037172.70296.287110.835121.427
存货周转天数 (天)316.841330.327200.373205.543231.390